CochLear Financials
| CHEOY Stock | USD 93.93 0.25 0.27% |
CochLear |
Understanding current and past CochLear Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of CochLear's financial statements are interrelated, with each one affecting the others. For example, an increase in CochLear's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in CochLear's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of CochLear Ltd ADR. Check CochLear's Beneish M Score to see the likelihood of CochLear's management manipulating its earnings.
CochLear Stock Summary
CochLear competes with Abbott Laboratories, Stryker, Boston Scientific, Medtronic PLC, and Siemens Healthineers. Cochlear Limited provides implantable hearing solutions for children and adults worldwide. The company was founded in 1981 and is headquartered in Sydney, Australia. Cochlear operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 4500 people.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| ISIN | US1914592050 |
| Business Address | 1 University Avenue, |
| Sector | Healthcare |
| Industry | Medical Devices |
| Benchmark | Dow Jones Industrial |
| Website | www.cochlear.com |
| Phone | 61 2 9428 6555 |
| Currency | USD - US Dollar |
CochLear Key Financial Ratios
CochLear's financial ratios allow both analysts and investors to convert raw data from CochLear's financial statements into concise, actionable information that can be used to evaluate the performance of CochLear over time and compare it to other companies across industries.| Return On Equity | 0.17 | |||
| Return On Asset | 0.0973 | |||
| Beta | 0.43 | |||
| Z Score | 22.8 | |||
| Last Dividend Paid | 3.0 |
CochLear Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining CochLear's current stock value. Our valuation model uses many indicators to compare CochLear value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across CochLear competition to find correlations between indicators driving CochLear's intrinsic value. More Info.CochLear Ltd ADR is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.57 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for CochLear Ltd ADR is roughly 1.76 . Comparative valuation analysis is a catch-all model that can be used if you cannot value CochLear by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for CochLear's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.CochLear ADR Systematic Risk
CochLear's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. CochLear volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Beta measures systematic risk based on how returns on CochLear ADR correlated with the market. If Beta is less than 0 CochLear generally moves in the opposite direction as compared to the market. If CochLear Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one CochLear ADR is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of CochLear is generally in the same direction as the market. If Beta > 1 CochLear moves generally in the same direction as, but more than the movement of the benchmark.
CochLear December 11, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of CochLear help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of CochLear Ltd ADR. We use our internally-developed statistical techniques to arrive at the intrinsic value of CochLear Ltd ADR based on widely used predictive technical indicators. In general, we focus on analyzing CochLear Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build CochLear's daily price indicators and compare them against related drivers.
| Information Ratio | (0.1) | |||
| Maximum Drawdown | 6.77 | |||
| Value At Risk | (2.02) | |||
| Potential Upside | 2.86 |
Additional Tools for CochLear Pink Sheet Analysis
When running CochLear's price analysis, check to measure CochLear's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CochLear is operating at the current time. Most of CochLear's value examination focuses on studying past and present price action to predict the probability of CochLear's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CochLear's price. Additionally, you may evaluate how the addition of CochLear to your portfolios can decrease your overall portfolio volatility.